To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer
Conditions
- Renal Cell Carcinoma (RCC)
Interventions
- DRUG: Anti-Human CD70 T-Cell Injection
Sponsor
Hrain Biotechnology Co., Ltd.
Collaborators